Research Platform Integrating Patient Reported and Clinical Outcomes Data Sources
Research Platform Integrating Patient Reported and Clinical Outcomes Data Sources
批准号:
8394790
负责人:
John Christopher Weiss
金额:
$14.95万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2013-08-28
关键词:
AddressAreaBlindedBudgetsClinicalClinical DataClinical ResearchClinical TrialsComputerized Medical RecordCost ControlDataData CollectionData SourcesDatabasesFaceFarGoFrequenciesGenetic TranscriptionGoalsGoldHealthIndividualInformation TechnologyLinkLogicManualsOnline SystemsOutcomeOutcome MeasureParticipantPatient Outcomes AssessmentsPatientsPhasePhase IV Clinical TrialsProcessProspective StudiesReportingResearchResearch ContractsResearch PersonnelResourcesSample SizeSecureSiteSolutionsSpecific qualifier valueSystemTestingTimeTranslational ResearchTreesUpdatebasecomparativecostdesignexperienceinnovationlarge-scale databaseprospectiveprototyperepositoryroutine caretoolusabilityuser-friendly
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): While large, prospective, blinded trials are the gold standard in clinical research, they require significant commitments of resources and time. Further, since these trials seek the answer to rather specific questions, the applicability and scalability of data obtained in these large trials is limited by the way in which it was collected.
These trials will likely continue to be the final word in translational research, but in the face o contracting research budgets it is increasingly important to conduct only those studies that have a reasonable likelihood of answering the research hypotheses. Another reality of large, prospective clinical studies is that study designers must make a number of critical decisions (e.g., sample size) before the first data are collected. While statistical analyses exist to estimae sample size, they are often based on incomplete and sometimes insufficient preliminary information. Prior to embarking on an expensive prospective study, it would be particularly advantageous for investigators to have access to a large repository of high quality, codified, de- identified patient data. Given the recent ascension and recognized importance of patient reported outcomes (PRO) data in clinical trials, Dynamic Clinical Systems (DCS) is developing a research platform to open access to its large scale database of clinical PRO data. DCS will provide a unique and innovative solution that enables sustainable data collection and secure data access by opening its Web-based PRO system to researchers. This will provide researchers with access to de-identified PRO data broadly collected during routine care and in clinical studies. Further, DCS will boost the breadth and depth of its PRO data by integrating with complementary data sources and linking longitudinal patient-centric data. The result will be a continuously populating, secure PRO database available to researchers through a user-friendly interface. In Phase I we will 1) integrate our PRO database with a partner database to demonstrate feasibility and 2) create a prototype interface for research access. Feasibility will be established if the integration prototype seamlessly transfers data and passes tree test scenarios. We will test usability by querying clinical researchers as they use the interface prototype.
PUBLIC HEALTH RELEVANCE: Patient-reported outcomes (PRO) measured with sophisticated, yet easy-to-use assessments are a key way in which patients and study participants can communicate with their clinician or study coordinator, respectively. Dynamic Clinical Systems is developing an information technology solution that automates this process so that clinical trials are less expensive, require fewer numbers of participants, are less burdensome, and collect information about the patient's experience from the patient's perspective.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Web-based Patient-Reported Outcomes (PRO) System for Breast Cancer Survivors
-
批准号:7935397
-
项目类别:
-
资助金额:$48.3万
-
财政年份:2009
-
负责人:John Christopher Weiss
-
依托单位:
Web-based Patient-Reported Outcomes (PRO) System for Breast Cancer Survivors
-
批准号:7836763
-
项目类别:
-
资助金额:$48.41万
-
财政年份:2009
-
负责人:John Christopher Weiss
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: